Category Medicine and Healthcare
Press Release
Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement
Plans to conduct consumer and safety testing during second quarter 2025 Desert Stream Inc.,a leading private label manufacturer in the health and wellness industry, performing initial production Single dose pre-workout supplement expected to be available in at least three flavors and launch in specialty retailers of nutritional products in 2025 Read More
Press Release
Top 5 Digital Strategies Advancing Healthcare Consumer Engagement in 2025 - Insights From Black Book's National Multistakeholder Poll
Survey of 1,672 healthcare providers and 200 healthcare consumers reveals aligned and divergent perspectives on digital tools, engagement barriers, and strategies driving success in 2025 Read More
Press Release
Icotrokinra Results Show 75% of Adolescents with Plaque Psoriasis Achieved Completely Clear Skin and Demonstrate Favorable Safety Profile with a Once Daily Pill
84% of adolescents with moderate-to-severe plaque psoriasis treated with investigational icotrokinra achieved clear or almost clear skin (IGA 0/1) at Week 16 ICONIC-LEAD is the first ever Phase 3 registrational study in moderate-to-severe plaque psoriasis to assess safety and efficacy of a systemic therapy in adolescents and adults simultaneously Read More
Press Release
How the DEA Is Trying to Railroad MMJ Biopharma Marijuana Cultivation in Defiance of Supreme Court Axon Ruling
"MMJ BioPharma Cultivation is engaged not only in a fight for justice but for the integrity of our legal system. As we stand against the DEA's disregard for Supreme Court directives, we are not merely defending our rights; we are upholding the principle that the DEA should not be above the law, especially not one that regulates medical progress. This isn't just our battle-it's a stand for every American whose life and liberties depend on the fair application of justice." - Duane Boise, CEO of MMJ BioPharma Cultivation Read More
Press Release
Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
One clinical trial site activated Patient enrollment expected in April Trial designed to evaluate safety, pharmacokinetics and pharmacodynamics, of Aspire's sublingual aspirin product Aspire anticipates releasing initial clinical data from trial at the end of the second quarter Aspire intends to request "fast track" approval on FDA application for its high-dose aspirin product Read More
Press Release
DEA’s Marijuana Double Standard: Attorney Aarathi Haig Flouts Ethics Laws While Blocking MMJ’s Cannabis Research
Duane Boise CEO of MMJ International Holdings stated, “When private citizens or companies fall short of compliance, the DEA acts swiftly and decisively. The question is, why is there no comparable urgency when the failure comes from within the DEA's own ranks? The agency's silence on this matter is not just a public relations problem—it's a breach of public trust." Read More
Press Release
viemaa Launches Innovative BOND SHAMPOO to Indulge, Cleanse, Fortify and Revive Hair
The new shampoo combines natural ingredients and a patented Biomimetic Cuticle Technology in a formula that is scientifically proven to repair damaged hair and make it easier than ever to detangle, smooth and style. Read More
Press Release
Tariff Tsunami Hits U.S. Healthcare: Double-Digit Penalties Spark Cost Surge and Supply Chain Crisis, Black Book Warns
Black Book's ad hoc survey of 200 healthcare executives reveals real-time disruptions, cost inflation, and stalled innovation as Trump-era tariffs expand across key healthcare imports. Read More
Press Release
Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product
Gelclair® is the company's third commercialized prescription product Oral mucositis, also called "chemo mouth," a painful inflammation of the mouth's mucous membranes, has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task force Napo's core target patient audiences for Gelclair are head and neck cancer patients and bone marrow transplant patients Read More
Press Release
Interactive Strength Inc. (NASDAQ "TRNR") Signs Binding Agreement to Acquire Wattbike, a $15M+, Omni-Channel, Connected, Indoor- Performance-Bike Business
Transaction Expected to Help TRNR Generate More than $65M in 2025 Revenue on a Pro Forma basis Wattbike is the Leading, Indoor-Bike Brand for Elite-Athlete Training and is Used by Olympians and Professional Sports Teams Worldwide - Including the NFL, NBA, MLB, NHL and Premier League TRNR Listing, Global Distribution Network to Help Wattbike Accelerate Growth, Especially in Key Markets Like US and Germany; Wattbike's Deep Penetration into Leading UK Gyms and Expanding D2C Customer Base to Similarly Speed Up Step-Changes to TRNR Top and Bottom Lines Transaction Delivers on Previously-Announced LOI, Combines Highly Complementary Businesses to Create a Scaled, International Operation Anchored in the US, Germany and UK, the #1, #2 and #3 Fitness Markets Globally Deal - Expected to be TRNR's 3rd Within a Year-and-a-Half - Builds on its Transformative Portfolio Strategy for Creating Long-Term Shareholder Value Acquisition Expected to Close as Early as the Second Quarter of 2025, Subject to Standard Regulatory Requirements Read More
Press Release
Federal Probe DEA - MMJ Marijuana Application Drug Development - 7 Years Delayed As HD Patients Suffering
Central to the probe are DEA's Thomas Prevoznik, DEA's Matthew Strait and DEA attorney Aarathi Haig within the DEA's Diversion Control Division, whose conduct has raised serious questions about the integrity of the DEA's regulatory processes. Read More
Press Release
Ankle & Foot Centers of America Offers Tips for National Foot Health Awareness Month
During April, the top-rated multi-state podiatry practices emphasizes daily hygiene, exercise, preventive care and early intervention to resolve minor foot issues before they can become major health problems. Read More
Press Release
DEA Marijuana Enforcers Fail the Law: The DEA Chief Council Attorney Aarathi Haig Not in Good Standing
"This isn't just about paperwork - it's about a pattern of disregard for the law," said Duane Boise CEO MMJ International Holdings. "The DEA can't demand compliance from others while ignoring its own obligations." Aarathi D. Haig, a DEA attorney central to the agency's controversial handling of MMJ Biopharma Cultivation's Bulk Manufacturers cannabis research application, is not in good standing with the New Jersey Bar. A February 2023 letter from the New Jersey Board of Bar Examiners states Haig is ineligible for a Certificate of Good Standing Read More
Press Release
Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Sea's pre-clinical stage neurotherapeutic synthetic oral molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the CNS (central nervous system) Sea's lead molecule SPM-0404 is a potential new oral treatment in investigational new drug (IND)-enabling studies for constant bothersome tinnitus, epilepsy, and sporadic ALS (S-ALS) Pre-clinical development work by Inotiv, Inc. to support Sea filing IND application at FDA Inotiv Inc will assist Sea to quantify SPM-0404 levels in Clinical Phase 1 and Ph.1b Trials Read More
Press Release
